siRNA treatment reduces triglycerides in individuals with unusual health condition

.RESEARCH STUDY EMPHASIZE.19 September 2024.

Plozasiran lessened triglyceride levels by 80% and also decreased the risk of pancreatitis in individuals along with relentless chylomicronemia, along with or even without a genetic medical diagnosis.